Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article from TechnoBleak included an article published in a supplement to The American Journal of Managed Care® (AJMC®). The article, “Idiopathic Pulmonary Fibrosis: The Role of the Pharmacy Benefit Manager in Providing Access to Effective, High-Value Care,” explored the high costs associated with idiopathic pulmonary fibrosis and the role of pharmacy benefit managers in managing the cost and appropriate utilization of new treatments through disease management programs, negotiated discounts and rebates, improved adherence to treatment recommendations, and benefit design to optimize patient care.
The National Pharmaceutical Council’s Tuesday and Wednesday CER Daily Newsfeeds included AJMC®’s coverage of the ISPOR 2019 annual meeting. The article, “The Imperfect QALY: How It’s Used Depends on Where You Enter Value Discussions,” covered a session in which panelists discussed the good and the bad about the quality-adjusted life year metric from their various perspectives. The newsfeeds also included the article, “Bringing Financial Theory Into the Value Equation of Future Cutting-Edge Therapies,” which covered a session that discussed the work of a researcher who recently published part of her dissertation on real option value, as used in pharmaceutical assessment, as well as an AJMC® interview with Paul Melmeyer, director of Federal Policy, National Organization for Rare Disorders, who discussed the importance of value assessments taking into account the unique characteristics of a disease.
Thursday’s newsfeed included an article from AJMC®’s sister site The Center for Biosimilars®. The article, “Health Canada Approves Its First Biosimilar Trastuzumab, Ogivri,” covered Health Canada’s approval of Mylan and Biocon’s trastuzumab biosimilar Ogivri, referencing Herceptin, which carries indications for HER2-positive breast cancer and HER2-positive metastatic stomach cancer.
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Many Patients With Psoriasis in Clinical Trials Experience Nocebo Effects, Study Finds
April 18th 2024Half of patients exposed to placebo in clinical trials experienced adverse events (AEs), which may be partially explainable by nocebo effects, according to a recent review and meta-analysis.
Read More
Low-Volume Hospitals Had Higher Reoperation Rate, Postoperative Complications in CRC
April 18th 2024Patients opting for elective colorectal surgery to address colorectal cancer (CRC) could have different rates of reoperation and postoperative complications based on the size of the hospital.
Read More